SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001654954-18-004574
Filing Date
2018-05-01
Accepted
2018-05-01 09:12:30
Documents
4
Effectiveness Date
2018-05-01

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT azrxs3mef_may12018.htm S-3MEF 71322
2 OPINION ON LEGALITY ex5-1.htm EX-5.1 11857
3 CONSENTS OF EXPERTS AND COUNSEL ex23-1.htm EX-23.1 4207
4 IMAGE dlg.jpg GRAPHIC 3929
  Complete submission text file 0001654954-18-004574.txt   94037
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3MEF | Act: 33 | File No.: 333-224562 | Film No.: 18793466
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1